11.60USD+1.40%Mkt Cap: 349.47M USDP/E: —Last update: 2026-05-26
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap349.47M USD
Enterprise Value378.87M USD
Revenue (TTM)40.61M USD
Gross Profit22.69M USD
Net Income (TTM)-25.54M USD
Revenue/Share1.412 USD
Last Price11.60 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees172
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.45
PEG0.61
EV/EBITDA-16.05
EV/Revenue9.33
P/S8.64
P/B18.63
EPS (TTM)-1.00
EPS (Forward)-0.94
52W Range
8.27015% of range30.10
52W High30.10 USD
52W Low8.270 USD
Profitability
Gross Margin61.38%
Oper. Margin-69.90%
EBITDA Margin-58.12%
Profit Margin-69.08%
ROE-91.15%
ROA-26.13%
Growth
Revenue Growth42.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.93M USD
CapEx (TTM)522.00K USD
FCF Margin-28.64%
FCF Yield-3.33%
Net Debt28.00M USD
Net Debt/EBITDA-1.19
Balance Sheet
Debt/Equity2.08
Current Ratio5.79
Quick Ratio4.75
Book Value/Sh0.6280 USD
Cash/Share1.187 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:40
Split DateJul 27, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)22.00 USD
Target Range16.00 USD – 30.00 USD
# Analysts3
Ownership
Shares Out.29.99M
Float25.44M
Insiders8.41%
Institutions50.66%
Short Interest
Short Ratio10.0d
Short % Float17.06%
Short % Out.16.48%
Shares Short4.94M
Short (prev mo.)4.43M
Technical
SMA 5010.59 (+9.5%)
SMA 20014.11 (-17.8%)
Beta1.29
S&P 52W Chg28.31%
Avg Vol (30d)504.31K
Avg Vol (10d)723.95K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—